Bank of Montreal
SLN

Bank of Montreal’s Silence Therapeutics SLN Stock Holding History

Bank of Montreal’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
202,901
+42,427
+26% +$234K ﹤0.01% 2005
2025
Q4 		$976K Buy
160,474
+6,692
+4% +$42.8K ﹤0.01% 1994
2025
Q3 		$798K Buy
153,782
+7,970
+5% +$44.3K ﹤0.01% 2061
2025
Q2 		$846K Sell
145,812
-12,781
-8% -$54.8K ﹤0.01% 1988
2025
Q1 		$447K Buy
158,593
+93,586
+144% +$457K ﹤0.01% 2270
2024
Q4 		$447K Sell
65,007
-252
-0.4% -$3.25K ﹤0.01% 2295
2024
Q3 		$1.19M Buy
+65,259
New +$1.21M ﹤0.01% 1943

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Bank of Montreal's SLN Position: Q1 2026 in Review

Bank of Montreal increased its Silence Therapeutics (SLN) stake by 26% in Q1 2026, buying an estimated $234K and bringing the position to 202,901 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2005.

Bank of Montreal first reported a position in SLN in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q3 2024. 56 funds tracked by Wall St. Rank hold SLN as of Q1 2026.

  • Bank of Montreal held 202,901 shares of Silence Therapeutics worth $1.07M as of Q1 2026.
  • Bank of Montreal bought 42,427 Silence Therapeutics shares in Q1 2026, an estimated $234K.
  • Silence Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2005 holding.
  • Bank of Montreal first reported a position in Silence Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Bank of Montreal's Silence Therapeutics position peaked at $1.19M in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Silence Therapeutics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.